-810.jpg) |
|
Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for diagnosis, treatment and follow-up of diseases. Given the immense potential impact of nanomedicine on public wellbeing and on economic growth, the field is of considerable strategic importance for Europe.
The EuroNanoMed ERA-NET initiative comprises 24 partners from 18 countries/regions. EuroNanoMed aims at fostering the competitiveness of European nanomedicine players through the support of trans-national collaborative and multidisciplinary Research and Technology Development (RTD) projects with participants from academia, clinical/public health communities, and industry (particularly small and medium-sized enterprises).
|
|
RESULTS OF THE 1ST CALL
DOWNLOAD PRESS RELEASE: EuroNanoMed promotes European collaborations and innovations in nanomedicine.
|
Following the recommendations of the Peer Review Panel that were based on overall quality assessment of all eligible applications received in response to the Joint Call, the Call Steering Committee of EuroNanoMed, at its meeting in Padova on October 16th, selected the following projects (listed according to the ranking by the Peer Review Panel):
|
|
|
ACRONYM
|
FULL TITLE
|
COORDINATOR
|
COORDINATING COUNTRY
|
|
1
|
DENANORNA
|
Dendrimers as nanovectors for targeted siRNA delivery in gene therapy
|
Ling Peng (Centre National Recherche Scientifique)
|
France
|
|
2
|
Nano4Neuro
|
Nano-Functionalised Implants for the Regenerative Treatment of Spinal Cord and Nerve Lesions
|
Burkhard Schlosshauer (Natural and Medical Sciences Institute at the University of Tübingen)
|
Germany
|
|
3
|
LYMPHOTARG
|
LYMPHONANOCARRIERS FOR THE TREATMENT OF METASTATIC CANCER
|
Maria José Alonso Fernández (University of Santiago de Compostela)
|
Spain
|
|
4
|
I-CARE
|
Integrative nano-Composites And Regeneration of the Eye
|
May Griffith (Linköpings University)
|
Sweden
|
|
5
|
EAREG
|
Ear Tissue Regeneration Using Human Cells and Novel Nano-Cellulose Scaffolds
|
Paul Gatenholm (Chalmers University of Technology)
|
Sweden
|
|
6
|
TARGET-PDT
|
Photo Dynamic Therapy using photosensitizer-doped targeted organic nanoparticles
|
Patrick Boisseau (CEA – Commissariat à l’énergie atomique)
|
France
|
|
7
|
DENPEPTHIV
|
Peptides-associated dendrimers in dendritic cells for the development of new nano-HIV vaccines
|
Mª Angeles Muñoz Fernández (Hospital General Universitario Gregorio Marañón)
|
Spain
|
|
8
|
NANOSTEM
|
Targeting Combined Therapy to Cancer Stem Cells
|
Simó Schwartz Jr (CIBER-BBN)
|
Spain
|
The final budget of each funded project partner is to be negotiated and specified by the relevant funding agency.
|
|
|
